Real-world persistence of twice-weekly teriparatide and factors associated with the discontinuation in patients with osteoporosis

ConclusionOne year continuation rate of 2/W-TPD was higher than the previously reported value of the once-weekly formulation in real-world setting, probably due to the lower incidence of side effects. Introducing injection of 2/W-TPD may further improve the persistence of TPD therapy for osteoporosis.
Source: Journal of Bone and Mineral Metabolism - Category: Orthopaedics Source Type: research